GILDER GAGNON HOWE & CO LLC

Position in ARQT — Arcutis Biotherapeutics, Inc.

CIK 902464 New York, NY

Position in ARQT

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$101,402,475

-$27,937,503 QoQ

Shares Held

4,304,010

-3.4% QoQ

Ownership

3.44%

of shares outstanding

% of Portfolio

1.24%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2024

9 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Healthcare · as of Mar 31, 2026

GILDER GAGNON HOWE & CO LLC holds $340,397,266 across 19 Biotechnology names. ARQT ranks #1 (29.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ARQT	Arcutis Biotherapeutics, Inc. This page	4,304,010	$101,402,475
2	ALNY	Alnylam Pharmaceuticals, Inc.	280,092	$92,674,040
3	BBIO	BridgeBio Pharma, Inc.	420,325	$31,213,334
4	CYTK	Cytokinetics Inc	330,989	$21,815,484
5	KYMR	Kymera Therapeutics, Inc.	235,433	$19,609,214
6	NKTR	Nektar Therapeutics	271,758	$19,552,988
7	MDGL	Madrigal Pharmaceuticals, Inc.	29,391	$15,385,306
8	KRYS	Krystal Biotech, Inc.	40,128	$10,365,864

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$101,402,475	4,304,010	-3.4%	Shares	Sole	2026-05-15
2025-12-31	$129,339,978	4,453,856	+0.6%	Shares	Sole	2026-02-17
2025-09-30	$83,488,685	4,429,108	+6.6%	Shares	Sole	2025-11-14
2025-06-30	$58,263,797	4,155,763	+1.5%	Shares	Sole	2025-08-14
2025-03-31	$64,062,237	4,096,051	+4.9%	Shares	Sole	2025-05-15
2024-12-31	$54,368,664	3,902,991	+9.8%	Shares	Sole	2025-02-14
2024-09-30	$33,050,693	3,553,838	-1.7%	Shares	Sole	2024-11-14
2024-06-30	$33,633,747	3,616,532	-14.6%	Shares	Sole	2024-08-14
2024-03-31	$41,968,364	4,234,951	—	Shares	Sole	2024-05-15
No filing history on record for this holder in this stock.